Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours

被引:70
作者
Yao, Y [1 ]
Kubota, T [1 ]
Sato, K [1 ]
Kitai, R [1 ]
Takeuchi, H [1 ]
Arishima, H [1 ]
机构
[1] Fukui Med Univ, Dept Neurosurg, Fukui, Japan
关键词
vascular endothelial growth factor; vascular endothelial growth factor receptors; prognosis; astrocytic tumours;
D O I
10.1007/s007010170122
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) is an important regulator of angiogenesis and vascular permeability. Method. We examined immunohistochemically expressions of VEGF and its corresponding receptors Flt-1 and Flk-1 in a series of 50 astrocytic tumours, and correlated their expressions with the degree of angiogenesis, brain edema and prognosis. Findings. There were significant relationships between VEGF, Flk-1 expressions and glioma malignancy grading, intratumoural vascularity and peritumoural brain edema, respectively. Patients with VEGF positive low grade astrocytoma and glioblastoma multiforme had a significantly shorter mean overall survival time than those with negative tumours (P = 0.0010 and 0.0180, respectively). Flk-1 is also a significant prognostic factor within each tumour grade, which has a negative impact on overall survival. Additionally, overexpression of VEGF and Flk-1 were significantly associated with earlier recurrence in patients with low grade astrocytomas (P = 0.0018 and 0.0240, respectively). Interpretation. It is possible to subcategorize each grade of astrocytic tumours based on their VEGF and Flk-1 staining pattern, which may be crucial in predicting the biological behavior of tumours and thus provide useful information with regard to adequate treatment.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 45 条
[1]   Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma [J].
Abdulrauf, SI ;
Edvardsen, K ;
Ho, KL ;
Yang, XY ;
Rock, JP ;
Rosenblum, ML .
JOURNAL OF NEUROSURGERY, 1998, 88 (03) :513-520
[2]  
BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO
[3]  
2-D
[4]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[5]   THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF POLYPEPTIDES [J].
FERRARA, N ;
HOUCK, KA ;
JAKEMAN, LB ;
WINER, J ;
LEUNG, DW .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :211-218
[6]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[7]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[8]  
Harada H, 1999, CANCER RES, V59, P3783
[9]   Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice [J].
Hiratsuka, S ;
Minowa, O ;
Kuno, J ;
Noda, T ;
Shibuya, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9349-9354
[10]   HYPOXIA-INDUCED TRANSCRIPTIONAL ACTIVATION AND INCREASED MESSENGER-RNA STABILITY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN C6 GLIOMA-CELLS [J].
IKEDA, E ;
ACHEN, MG ;
BRIER, G ;
RISAU, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19761-19766